← Back
Data updated: Mar 10, 2026
FOSUN WANBANG
CardiovascularOncologyGastroenterology
FOSUN WANBANG is a generic drug manufacturer focused on Cardiovascular, Oncology, Gastroenterology.
2005
Since
4
Drugs
-
Trials
33
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
MYCOPHENOLATE SODIUM 2026-01-14
Labeling
LEFLUNOMIDE 2025-10-24
Labeling
SUNITINIB MALATE 2025-07-22
Manufacturing (CMC)
GUANFACINE HYDROCHLORIDE 2025-04-15
SUNITINIB MALATE 2025-02-14
GUANFACINE HYDROCHLORIDE 2025-02-12
Labeling
MYCOPHENOLATE SODIUM 2024-12-19
Labeling
MYCOPHENOLATE SODIUM 2024-12-19
Labeling
MYCOPHENOLATE SODIUM 2024-12-19
Labeling
LEFLUNOMIDE 2024-12-17
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 33%
1 drugs
Oncology 33%
1 drugs
Gastroenterology 33%
1 drugs
Pipeline Strength Pro
Loading...
Discontinued (0)
Company Info
- First Approval
- 2005-09-13
- Latest
- 2024-06-12
- Applications
- 4